Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1980-12-17
1983-04-12
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
2602393R, 2602393B, 424258, 424263, 424267, 434274, 546141, 546156, 546203, 546205, 546206, 546221, 546243, 546292, 548512, 548528, 548538, A61K 3140, A61K 3144, C07D20738, C07D20946
Patent
active
043797857
ABSTRACT:
What are disclosed are sulfonyl ureas of the formula ##STR1## in which R.sup.1, X and Y are as defined in the specification, and their physiologically acceptable salts, pharmaceutical formulations on the basis of these compounds, and their use in the treatment of diabetes.
REFERENCES:
patent: 3336322 (1967-08-01), Weber et al.
patent: 3510496 (1970-05-01), Aumuller et al.
patent: 3646009 (1972-02-01), Winter et al.
patent: 3655756 (1972-04-01), Weber et al.
patent: 3819633 (1974-06-01), Ambrogi et al.
patent: 3962244 (1976-06-01), Weyer et al.
patent: 4282239 (1981-08-01), Weyer et al.
79102066.2, European Patent Application Published Jan. 1, 1980 (=AD).
Geisen Karl
Hitzel Volker
Regitz Gunter
Weyer Rudi
Hoechst Aktiengesellschaft
Rollins Alton D.
LandOfFree
Heterocyclic substituted sulfonyl ureas, and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted sulfonyl ureas, and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted sulfonyl ureas, and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-938503